Saladax Biomedical

About:

Saladax Biomedical is a commercial-stage therapeutics developer with an initial focus on oncology.

Twitter/X: Saladax

Top Investors: Ben Franklin Technology Partners of Northeastern Pennsylvania, Fosun Pharma, Golden Seeds, GE Capital, Excel Venture Management

Description:

Saladax develops rapid blood tests for point-of-care and for laboratory analyzers for use in psychiatry and oncology. The firm has been supplying laboratories and clinicians worldwide with revolutionary diagnostic solutions for more than 15 years.

Total Funding Amount:

$54.9M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Bethlehem, Pennsylvania, United States

Founded Date:

2004-01-01

Contact Email:

orders(AT)saladax.com

Founders:

Adrienne Choma, Salvatore J. Salamone

Number of Employees:

11-50

Last Funding Date:

2020-06-22

IPO Status:

Private

Industries: